Please enable Javascript to get a taste of that Hopium 👼

AVRO - Company Overview - AVROBIO Inc
AVROBIO Inc
NASDAQ: avro

$1.40

USD

-$0.05

-3.45%

Prev Close

$1.45

Today's Open

$1.46

Volume

267.36K

Market Cap

61.11M

Day Range

1.38

range triangle

1.46

52W Range

1.27

range triangle

1.90

Overview

AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases after a single dose worldwide. The company is headquartered in Cambridge, Massachusetts.

Read more
Current Price
15 min delay
Catalysts

There are currently no catalysts for AVRO. If there's something you'd like to see, feel free to reach out to us on discord.

Market Trend
SPDR S&P 500
Sector Trend
Healthcare
Sentiment
(beta)

Insufficient Data

Ratios
Valuation Ratios

EPS (TTM)

-2.862

P/E Ratio

0

Price to Sales

0

Price to Book

0.343

Profit Ratios

Profit Margin

0.00%

EBITDA Margin

-Infinity%

Net Profit Margin

-

ROA

-33.10%

Total Revenue

$0.00

Net Profit

$0.00

EV to EBITDA

1.147

EV to Revenue

0

Data source(s): Alpha Vantage